Report

Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart

Science  26 Mar 1999:
Vol. 283, Issue 5410, pp. 2080-2082
DOI: 10.1126/science.283.5410.2080

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Transforming growth factor–β (TGF-β) signaling is mediated by a complex of type I (TBRI) and type II (TBRII) receptors. The type III receptor (TBRIII) lacks a recognizable signaling domain and has no clearly defined role in TGF-β signaling. Cardiac endothelial cells that undergo epithelial-mesenchymal transformation express TBRIII, and here TBRIII-specific antisera were found to inhibit mesenchyme formation and migration in atrioventricular cushion explants. Misexpression of TBRIII in nontransforming ventricular endothelial cells conferred transformation in response to TGF-β2. These results support a model where TBRIII localizes transformation in the heart and plays an essential, nonredundant role in TGF-β signaling.

  • * To whom correspondence should be addressed. E-mail: joey.barnett{at}mcmail.vanderbilt.edu

View Full Text

Related Content